Is OPKO Health a Diagnostics Stock Worth Buying?

Multinational biopharmaceutical company OPKO Health’s (OPK) stock climbed nearly 13% in price last year when the company announced its plans to acquire ModeX Therapeutics. However, given the company’s declining financials…

Leave a comment

Your email address will not be published. Required fields are marked *